Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Akorn, Inc.
(NQ:
AKRX
)
14.51
USD
-0.04 (-0.27%)
Streaming Delayed Price
/ Updated:
11:44 AM EDT, May 23, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Akorn, Inc.
< Previous
1
2
3
4
5
6
7
Next >
AnalystChoice.com Brings You the Best Complimentary Research Report on PH, BHI, AKRX, INCY, IACI and HBAN
June 29, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by AnalystChoice.com (AC).
Read More
from
Marketwired News Releases
Akorn Acquires Capastat® Sulfate from Eli Lilly and Company
June 17, 2009
from
Business Wire News Releases
Akorn Announces Management Changes
June 09, 2009
from
Business Wire News Releases
TheFortuneFinancial.com Initializes Free Analyst Research on JMBA, AKRX, PRGO and XLNX
June 01, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by TheFortuneFinancial.com.
Read More
from
Marketwired News Releases
Daily Stock Alerts by PennyStockChaser: DVAX, MOT, GNBT, AKRX, BPZ and UNCO
May 29, 2009
from
PR Newswire
Akorn Reports First Quarter 2009 Financial Results
May 12, 2009
from
Business Wire News Releases
Akorn Issues Important Business Updates:-- Purchase of Existing Credit Facility ---- Renegotiation of Distribution Agreement --
April 01, 2009
from
Business Wire News Releases
Akorn Appoints Jeffrey A. Whitnell as Interim Chief Executive Officer
March 30, 2009
from
Business Wire News Releases
ANI Pharmaceuticals Appoints Arthur S. Przybyl as Chief Executive Officer
March 09, 2009
from
Business Wire News Releases
Akorn Appoints Raj Rai as Strategic Consultant
March 02, 2009
from
Business Wire News Releases
Akorn Amplifies Form 8-K Disclosure
February 25, 2009
from
Business Wire News Releases
Akorn Announces Management Change
January 29, 2009
from
Business Wire News Releases
Beacon Equity Issues Trade Alerts on Market Movers: AFFX, ALL, LM, AKRX, SEPR, BA
January 29, 2009
from
PR Newswire
Akorn-Strides, LLC Announces FDA Approvals for Sterile Vancomycin HCl USP, 500 mg/Vial; 1 g/Vial and Sterile Vancomycin HCl USP, 5 g/Vial Pharmacy Bulk Package
December 31, 2008
from
Business Wire News Releases
Akorn, Inc. Responds to FDA Draft Guidance for Industry on Bioequivalence Recommendation for Vancomycin HCl
December 16, 2008
from
Business Wire News Releases
Akorn, Inc. Announces FDA Approval of Ciprofloxacin HCl Ophthalmic Solution USP, 0.3%
December 12, 2008
from
Business Wire News Releases
Akorn, Inc. Signs Memorandum of Understanding with Bioluz S.A. for Five Premix Products
November 24, 2008
from
Business Wire News Releases
Akorn Enters into a Five Year Contract Manufacturing Agreement to Supply an Ophthalmic Product
November 20, 2008
from
Business Wire News Releases
Akorn, Inc. to Present at the Credit Suisse Healthcare Conference
November 06, 2008
from
Business Wire News Releases
Akorn Reports Record Third Quarter 2008 Revenues of $31.9 million; Earnings per Share of $0.03
November 03, 2008
from
Business Wire News Releases
Elite Pharmaceuticals Elects Wall Street Veteran Jerry Treppel to the Board of Directors
November 03, 2008
from
GlobeNewswire News Releases
Akorn-Strides, LLC Announces FDA Approval for Pamidronate Disodium Injection, 3 mg/mL and 9 mg/mL
November 03, 2008
from
Business Wire News Releases
Akorn, Inc. Announces FDA Approval of Adenosine Injection USP, 3 mg/mL
November 03, 2008
from
Business Wire News Releases
Akorn, Inc. to Present at the Oppenheimer 19th Annual Healthcare Conference
October 21, 2008
from
Business Wire News Releases
Akorn, Inc. Announces Third Quarter 2008 Earnings Release and Conference Call Information
October 20, 2008
from
Business Wire News Releases
Akorn, Inc. Announces the Launch of Akten(TM) Gel 3.5%
October 15, 2008
from
Business Wire News Releases
Akorn, Inc. Enters into a Commercial Manufacturing Supply Agreement
October 13, 2008
from
Business Wire News Releases
Akorn, Inc. Announces the FDA Approval of Akten(TM) Ophthalmic Gel 3.5%
October 08, 2008
from
Business Wire News Releases
Beacon Equity Issues Technical Trade Alerts on Market Movers: ELRA, VLNC, DLIA, AKRX, ABX, GLD
September 30, 2008
from
PR Newswire
Akorn Enters into an Exclusive Contract Manufacturing Supply Agreement
September 11, 2008
from
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here